Since IFN-γ is an essential mediator of host defense against T. gondii [50], the administration of anti-IFN-γ mAb to the mice during the chronic stage of infection neutralizes the cytokine and induces reactivation of chronic infection both in the brain and the periphery [51]. The gene discussed is IFNG; the disease is infection.